As recent literature postulated SH3BGRL2, a homolog of SH3BGR, to affect the Hippo signaling pathway in renal cell carcinoma, we aimed to find whether SH3BGR affects Hippo signaling in neonatal cardiomyocytes [31]. Here, SH3BGRL2 is linked to hereditary clear cell renal cell carcinoma.